-
Sector Analysis
NewSeasonings, Dressings and Sauces Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Seasonings, Dressings, and Sauces Market Report Overview The seasonings, dressings, and sauces sector was valued at $176.4 billion in 2023 and will grow at a CAGR of more than 5% during 2023-2028. The market for seasonings, dressings & sauces has benefited from the rising health & wellness (H&W) trend. Consumers’ inclination towards healthier ingredients has spurred the demand for seasonings, dressings & sauces with claims such as natural, organic, preservative-free, and low in sugar/fat. Moreover, busy lifestyles, rapid urbanization, rising disposable...
-
Product Insights
NewBronchiectasis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Bronchiectasis Clinical Trial Report Overview A total of 394 Bronchiectasis clinical trials were conducted as of March 2024. The Bronchiectasis clinical trial report provides a comprehensive understanding of the Bronchiectasis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions · Asia-Pacific · Europe · North America · ...
-
Product Insights
Lupus Nephritis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Lupus Nephritis Clinical Trial Report Overview A total of 434 lupus nephritis clinical trials were conducted as of February 2024. The lupus nephritis clinical trial report provides a comprehensive understanding of the lupus nephritis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions · Asia-Pacific · North...
-
Product Insights
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
A total of 721 Hemophilia A (Factor VIII Deficiency) clinical trials were conducted as of February 2024. The Hemophilia A clinical trial report provides a comprehensive understanding of the Hemophilia A (Factor VIII Deficiency) clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions · Asia-Pacific · Europe...
-
Product Insights
United Kingdom (UK) Charity Insurance Market Dynamics, Trends, Opportunities and Future Market
United Kingdom (UK) Charity Insurance Market Report Overview The gross written premiums (GWP) in the non-profit insurance (including charities) in the United Kingdom (UK) was estimated at GBP1.04 billion in 2023. Voluntary organizations are essential in many different fields. Of these, social services make up the largest portion, accounting for almost one-fifth of the sector's total size. The public provides nearly half of the voluntary sector's income, with the government providing for nearly one third of it as well, explaining...
-
Product Insights
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Methicillin-Resistant Staphylococcus Aureus (MRSA) Clinical Trial Report Overview A total of 418 MRSA clinical trials were conducted as of January 2024. The MRSA clinical trial report provides a comprehensive understanding of the MRSA clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions · Asia-Pacific · Europe · ...
-
Sector Analysis
United Kingdom (UK) ICT Market Size and Forecast (by IT Solution Area, Size Band and Vertical) to 2027
United Kingdom ICT Market Overview The United Kingdom ICT market was valued at US$ 152.55 billion in 2022 and will grow at a compounded annual growth rate (CAGR) of 10.24% to reach a value of US$ 248.36 billion by 2027. The cumulative revenue generation for ICT providers in the United Kingdom is estimated at US$ 1,165.21 billion for 2022-2027. United Kingdom ICT Market Outlook, 2022-2027 (in US$ Billion) Buy the Full Report for More Insights into the United Kingdom ICT...
-
Thematic Analysis
Biosimilars in Oncology – Thematic Intelligence
Accessing in-depth insights from the ‘Biosimilars in Oncology’ report will help you: Understand the milestones of biosimilars in oncology, the trends in the market, and the biosimilar value chain. Assess the marketed and pipeline products and their uptake across 8MM. Learn about the percentage of cancer patients treated with biosimilars, the price of the agents compared to their originator, and key opinion leaders’ outlook for the products. Examine the 8MM regulatory landscapes, their market potential, and their available and upcoming biosimilars....
-
Product Insights
Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Gall Bladder Cancer Clinical Trial Report Overview A total of 620 Gall Bladder Cancer clinical trials were conducted as of December 2023. The Gall Bladder Cancer clinical trial report provides a comprehensive understanding of the Gall Bladder Cancer clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions...